Life expectancy and treatment choice for men with high-risk prostate cancer

European Urology

Volumn 68, Issue 1, 2015, Pages 59-60

  Daskivich, Timothy J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COMORBIDITY; EDITORIAL; HUMAN; LIFE EXPECTANCY; LOCAL THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; CLINICAL DECISION MAKING; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; REGISTER; UTILIZATION;

CLINICAL DECISION-MAKING; HUMANS; LIFE EXPECTANCY; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; REGISTRIES;

EID: 84942981097     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.01.006     Document Type: Editorial

References (10)

1. Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007; 177:2106-31.
2. Mohler J, Bahnson RR, Boston B, et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Cancer Netw 2010; 8:162-200.
3. Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 2014;65:124-37.
4. Daskivich TJ, Lai J, Dick AW, et al. Urologic Diseases in America Project. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer 2014;120:3642-50.
5. Lu-Yao GL, Albertsen PC, Moore DF. Outcomes of localized prostate cancer following conservative management. JAMA 2009;302: 1202-9.
6. Bradley CJ, Dahman B, Anscher M. Prostate cancer treatment and survival: evidence for men with prevalent comorbid conditions. Med Care 2014;52:482-9.
7. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28:1117-23.
8. Daskivich TJ, Chamie K, Kwan, et al. Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer 2013;119:3446-53.
9. Bratt O, Folkvaljon Y, Eriksson MH, et al. Undertreatment of men in their seventies with high-risk nonmetastatic prostate cancer. Eur Urol 2015;68:53-8.
10. Daskivich TJ, Kang-Hsien F, Koyama T, et al. Impact of age, tumor risk, and comorbidity on competing risks for survival in a US population-based cohort of men with prostate cancer. Ann Intern Med 2013;158:709-17.